Israel Englander’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,829,261
Closed -$20.4M 6991
2023
Q1
$20.4M Buy
2,829,261
+1,501,100
+113% +$11.6M 0.01% 1324
2022
Q4
$10.9M Buy
1,328,161
+296,392
+29% +$2.76M 0.01% 2043
2022
Q3
$10.9M Buy
1,031,769
+161,026
+18% +$1.71M 0.01% 2023
2022
Q2
$8.04M Buy
870,743
+112,867
+15% +$923K 0.01% 2293
2022
Q1
$5.21M Sell
757,876
-3,083,130
-80% -$19.9M ﹤0.01% 2884
2021
Q4
$30.9M Sell
3,841,006
-75,194
-2% -$499K 0.02% 1062
2021
Q3
$24M Buy
3,916,200
+3,183,404
+434% +$12.1M 0.01% 1157
2021
Q2
$2.28M Buy
+732,796
New +$2.8M ﹤0.01% 3801
2021
Q1
Sell
-68,847
Closed -$211K 6644
2020
Q4
$211K Buy
+68,847
New +$187K ﹤0.01% 4775
2020
Q3
Sell
-126,326
Closed -$1.3M 4941
2020
Q2
$1.3M Buy
+126,326
New +$1.28M ﹤0.01% 2833
2020
Q1
Sell
-28,548
Closed -$217K 4701
2019
Q4
$217K Sell
28,548
-37,852
-57% -$259K ﹤0.01% 3839
2019
Q3
$424K Buy
+66,400
New +$468K ﹤0.01% 3359

Other funds holding BLU

Israel Englander's BLU Position: Q2 2023 in Review

Israel Englander sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 2,829,261 shares — an estimated $20.4M sold.

Israel Englander first reported a position in BLU in Q3 2019 and held it in 12 quarters. The position peaked at $30.9M in Q4 2021. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Israel Englander reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Israel Englander sold 2,829,261 BELLUS Health Inc. shares in Q2 2023, an estimated $20.4M.
  • Israel Englander first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 12 quarters.
  • Israel Englander's BELLUS Health Inc. position peaked at $30.9M in Q4 2021.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.